Dokuz Eylul University Izmir

Izmir 35340

0 studies enrolling now · 2 studies all time

What they study most

Crohn Disease, Lymphoma, Non-Hodgkin

Studies at this site

• Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed
• A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease — Withdrawn before enrolling